Details for New Drug Application (NDA): 217927
✉ Email this page to a colleague
The generic ingredient in COXANTO is oxaprozin. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
Summary for 217927
Tradename: | COXANTO |
Applicant: | Solubiomix |
Ingredient: | oxaprozin |
Patents: | 0 |
Pharmacology for NDA: 217927
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 217927
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
COXANTO | oxaprozin | CAPSULE;ORAL | 217927 | NDA | Solubiomix, LLC | 69499-403 | 69499-403-60 | 60 CAPSULE in 1 BOTTLE (69499-403-60) |
COXANTO | oxaprozin | CAPSULE;ORAL | 217927 | NDA | Ayurax, LLC | 73308-403 | 73308-403-60 | 60 CAPSULE in 1 BOTTLE (73308-403-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Oct 20, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription